179 related articles for article (PubMed ID: 30848985)
21. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
[TBL] [Abstract][Full Text] [Related]
23. The importance of serum interleukin-20 levels in patients with Behçet's disease.
Enecik ME; Mavi B; Yücel Ç; Keskin G; Yıldız M
Adv Clin Exp Med; 2018 Oct; 27(10):1391-1395. PubMed ID: 30048054
[TBL] [Abstract][Full Text] [Related]
24. Association of Reduced Heme Oxygenase-1 with Decreased MicroRNA-196a2 Expression in Peripheral Blood Mononuclear Cells of Patients with Intestinal Behcet's Disease.
Zou J; Ji DN; Shen Y; Guan JL; Zheng SB
Ann Clin Lab Sci; 2016 Dec; 46(6):675-679. PubMed ID: 27993883
[TBL] [Abstract][Full Text] [Related]
25. Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease.
Düzgün N; Ayaşlioğlu E; Tutkak H; Aydintuğ OT
Rheumatol Int; 2005 Jan; 25(1):1-5. PubMed ID: 14600787
[TBL] [Abstract][Full Text] [Related]
26. Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.
Lopalco G; Lucherini OM; Vitale A; Talarico R; Lopalco A; Galeazzi M; Lapadula G; Cantarini L; Iannone F
Medicine (Baltimore); 2015 Oct; 94(42):e1858. PubMed ID: 26496336
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
[TBL] [Abstract][Full Text] [Related]
28. Negative Association of Circulating MicroRNA-126 with High-sensitive C-reactive Protein and Vascular Cell Adhesion Molecule-1 in Patients with Coronary Artery Disease Following Percutaneous Coronary Intervention.
Wang JN; Yan YY; Guo ZY; Jiang YJ; Liu LL; Liu B
Chin Med J (Engl); 2016 Dec; 129(23):2786-2791. PubMed ID: 27900989
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome.
Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH
Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202
[TBL] [Abstract][Full Text] [Related]
30. Cytokines in Behçet's disease.
Sayinalp N; Ozcebe OI; Ozdemir O; Haznedaroğlu IC; Dündar S; Kirazli S
J Rheumatol; 1996 Feb; 23(2):321-2. PubMed ID: 8882039
[TBL] [Abstract][Full Text] [Related]
31. Levels of soluble E-selectin in patients with active Behçet's disease.
Sari RA; Kiziltunç A; Tays'y S; Akdem'yr S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 27520409
[TBL] [Abstract][Full Text] [Related]
32. Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet's Disease.
Icli A; Cure MC; Cure E; Arslan S; Unal M; Sakiz D; Ozucan M; Toker A; Turkmen K; Kucuk A
Acta Medica (Hradec Kralove); 2018; 61(3):86-92. PubMed ID: 30543512
[TBL] [Abstract][Full Text] [Related]
33. [Protective effects of microRNA-181b on aged rats with sepsis-induced hippocampus injury in vivo].
Dong R; Hu D; Li Q; Xu T; Sui Y; Qu Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jul; 31(7):857-861. PubMed ID: 31441410
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
[TBL] [Abstract][Full Text] [Related]
35. Increased complexin-1 and decreased miR-185 expression levels in Behçet's disease with and without neurological involvement.
Uğurel E; Şehitoğlu E; Tüzün E; Kürtüncü M; Çoban A; Vural B
Neurol Sci; 2016 Mar; 37(3):411-6. PubMed ID: 26577184
[TBL] [Abstract][Full Text] [Related]
36. Serum-soluble selectin levels in patients with Behçet's disease.
Ateş A; Tiryaki OA; Olmez U; Tutkak H
Clin Rheumatol; 2007 Mar; 26(3):411-7. PubMed ID: 17206396
[TBL] [Abstract][Full Text] [Related]
37. IL-38 serum levels in patients with Behcet's disease and the relationship with clinical features.
Zarrabi M; Gholijani N; Shenavandeh S; Aflaki E; Amirghofran Z
Eur Cytokine Netw; 2019 Sep; 30(3):82-87. PubMed ID: 31957702
[TBL] [Abstract][Full Text] [Related]
38. The distinct expressions of interleukin-15 and interleukin-15 receptor α in Behçet's disease.
Choe JY; Lee H; Kim SG; Kim MJ; Park SH; Kim SK
Rheumatol Int; 2013 Aug; 33(8):2109-15. PubMed ID: 23417200
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
[TBL] [Abstract][Full Text] [Related]
40. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
